Cyclooxygenase-2 expression correlates with diminished survival in invasive breast cancer treated with mastectomy and radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 58, Issue 4, 2004, Pages 1034-1040

  O'Connor, John K ^a   Avent, James ^b   Lee, R Jeffrey ^b   Fischbach, Jennifer ^b   Gaffney, David K ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b LDS HOSPITAL   (United States)

Author keywords

Breast cancer; COX 2; Radiotherapy

Indexed keywords

CELLS; DISEASES; PARAFFINS; PATIENT TREATMENT; TUMORS;

BREAST CANCERS; MASTECTOMY;

RADIOTHERAPY;

CYCLOOXYGENASE 2;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER INVASION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EVALUATION; FEMALE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MASTECTOMY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; TISSUE FIXATION;

ADULT; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; CYCLOOXYGENASE 2; FEMALE; HUMANS; ISOENZYMES; MASTECTOMY; MEMBRANE PROTEINS; NEOPLASM PROTEINS; PROGNOSIS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; STATISTICS; SURVIVAL RATE;

EID: 1542316367     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.08.032     Document Type: Article

References (39)

1. The American Cancer Society web site. http://www.cancer.org/docroot/CRI/ content/CRI_2_4_1X_What_are_the_key_statistics_for_breast_cancer_5.asp.
2. Harris R.E., Kasbari S., Farrar W.B. Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer. Oncol Rep. 6:1999;71-73.
3. Harris R.E., Namboodiri K.K., Farrar W.B. Nonsteroidal antiinflammatory drugs and breast cancer. Epidemiology. 7:1996;203-205.
4. Schreinemachers D.M., Everson R.B. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology. 5:1994;138-146.
5. Khuder S.A., Mutgi A.B. Breast cancer and NSAID use A meta-analysis. Br J Cancer. 84:2001;1188-1192.
6. Soslow R.A., Dannenberg A.J., Rush D., et al. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer. 89:2000;2637-2645.
7. Pairet M, Engelhardt G. Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: Possible physiological and therapeutic implications. Fund Clin Pharmacol 1996;10:1-17.
8. Tsujii M., Kawano S., Tsuji S., et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 93:1998;705-716.
9. Tsujii M., Kawano S., DuBois R. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA. 94:1997;3336-3340.
10. Sheng H., Williams C.S., Shao J., et al. Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway. J Biol Chem. 273:1998;22120-22127.
11. Molina M.A., Sitja-Arnau M., Lemoine M.G., et al. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines Growth inhibition by nonsteroidal anti-inflammatory drugs. Cancer Res. 59:1999;4356-4362.
12. Zimmerman K.C., Sarbia M., Weber A.A., et al. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res. 59:1999;198-204.
13. Yoshimura R., Sano H., Masuday C., et al. Expression of cyclooxygenase-2 in prostate carcinoma. Cancer. 89:2000;589-596.
14. Khuri F.R., Wu H., Lee J.J., et al. Cycolooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clin Cancer Res. 7:2001;861-867.
15. Chan G., Boyle J.O., Yang E.K., et al. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res. 59:1999;991-994.
16. Shono T., Tofilon P.J., Bruner J.M., et al. Cyclooxygenase-2 expression in human gliomas Prognostic significance and molecular correlations. Cancer Res. 61:2001;4375-4381.
17. Masferrer J.L., Leahy K.M., Koki A.T., et al. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res. 60:2000;1306-1311.
18. Elder D.J., Halton D.E., Hague A., et al. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug Independence from COX-2 protein expression. Clin Cancer Res. 3:1997;1679-1683.
19. Tsujii M., DuBois R.N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell. 83:1995;493-501.
20. Ishiko O., Sumi T., Yoshida H., et al. Association between overexpression of cyclooxygenase-2 and suppression of apoptosis in advanced cancer of the uterine cervix after cyclic balloon-occluded arterial infusion. Oncol Rep. 8:2001;1259-1263.
21. Ryu H.S., Chang K.H., Yaang H.W., et al. High cyclooxygenase-w expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion. Gynecol Oncol. 76:2000;320-325.
22. Gaffney D.K., Holden J., Davis M., et al. Elevated levels of cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy. Int J Radiat Oncol Biol Phys. 49:2001;1213-1217.
23. Nakatsugi S., Ohta T., Kawamori T., et al. Chemoprevention by nimesulide, a selective cyclooxygenase-2 inhibitor, of 2-amino-1-methyl-6-phenylimidazo. [4, 5 -b]pyridine (PhIP)-induced mammary gland carcinogenesis in rats Jpn J Cancer Res. 91:2000;886-892.
24. Harris R.E., Alshafie G.A., Abou-Issa H., et al. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor. Cancer Res. 60:2000;2101-2103.
25. Matsunaga K., Yoshimi N., Yamada Y., et al. Inhibitory effects of nabumetone, a cyclooxygenase-2 inhibitor, and esculetin, a lipoxygenase inhibitor, on N-methyl-nitrosourea-induced mammary carcinogenesis in rats. Jpn J Cancer Res. 89:1998;496-501.
26. Abou-Issa H.M., Alshafie G.A., Seibert K., et al. Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis. Anticancer Res. 21:2001;3425-3432.
27. Connolly E.M., Harmey J.H., O'Grady T., et al. Cyclo-oxygenase inhibition reduces tumor growth and metastasis in an orthotopic model of breast cancer. Br J Cancer. 87:2002;231-237.
28. Kishi K., Petersen S., Petersen C., et al. Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor. Cancer Res. 60:2000;1326-1331.
29. Gaffney D.K., Holden J., Zempolich K., et al. Elevated COX-2 expression in cervical carcinoma Reduced cause-specific survival and pelvic control. Am J Clin Oncol. 24:2001;443-446.
30. Liu XH, Kirschenbaum A, Yao S, et al. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. J Urol 2000;164(3 Pt 1):820-825.
31. Murata H., Kawano S., Tsuji S., et al. Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma. Am J Gastroenterol. 94:1999;451-455.
32. Tomozawa S., Tsuno N.H., Sunami E., et al. Cyclooxygenase-2 overexpression correlates with tumor recurrence, especially hematogenous metastasis of colorectal cancer. Br J Cancer. 83:2000;324-328.
33. Ferrandina G., Lauriola L., Distefano M.G., et al. Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients. J Clin Oncol. 20:2002;973-981.
34. Ristimaki A., Sivula A., Lundin J., et al. Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res. 62:2002;632-635.
35. Spizzo G., Gastl G., Wolf D., et al. Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer in its impact on survival. Br J Cancer. 88:2003;574-578.
36. Haffty B.G., Fischer D., Rose M., et al. Prognostic factors for local recurrence in the conservatively treated breast cancer patient a cautious interpretation of the data. J Clin Oncol. 9:1991;997-1003.
37. Fowble B.L., Schultz D.J., Overmoyer B., et al. The influence of young age on outcome in early stage breast cancer. Int J Radiat Oncol Biol Phys. 30:1994;23-33.
38. Cotterchio M., Kreiger N., Sloan M., et al. Nonsteroidal anti-inflammatory drug use and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 10:2001;1213-1217.
39. Milas L, Kishi K, Hunter N, et al. Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme. J Natl Cancer Inst 1999;91:1501-1504.